CV Sciences Inc. (OTCMKTS: CVSI) has launched four distinctive over-the-counter +PlusCBD Pain Relief topicals that have been formulated to target sources of minor aches and pains...
CV Sciences Inc. (OTCMKTS: CVSI) has announced its third-quarter 2021 financial results for the period ending September 30, 2021. Revenue dropped to $5.1 million. In Q3...
CV Sciences Inc (OTCMKTS: CVSI) has been performing remarkably as a company focusing on hemp-derived cannabidiol (CBD) products, and today it highlights its plans for the future....